2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Propranolol on Post Stroke Immune Status and Infection Propranolol, Ceftriaxone - Stroke, Cerebrovascular Disorders | Phase 2 | Unknown | Tianjin Medical University General Hospital | 45 | 2022-06-01 | 2022-05-16 |
| Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. Dendritic Cell/Tumor Fusion Vaccine, Interleukin-12, Temozolomide - Glioblastoma, Glioma | Phase 1 / Phase 2 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 10 | 2020-12-01 | 2020-06-09 |
Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Glioblastoma (1) · Glioma (1) · Infections (1) · Ischemic Stroke (1) · Neoplasms (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Neuroectodermal Tumors (1) · Stroke (1)
Astrocytoma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Vascular Diseases (1)
Ceftriaxone (1) · Interleukin-12 (1) · Propranolol (1) · Temozolomide (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Tianjin Medical University General Hospital (1)
China (2)
Hong Shen, MD (1)